Evidence map›Paper›PMID 39699199›Full record

ArticleApplied and environmental microbiology2025

The healthy human gut can take it all: vancomycin-variable, linezolid-resistant strains and specific bacteriocin-species interplay in

Ana C Almeida-Santos, Bárbara Duarte, Ana P Tedim, Maria J Teixeira, Joana C Prata, Rui M S Azevedo, Carla Novais, Luísa Peixe, Ana R Freitas

Abstract read
In one paragraph

Article in Applied and environmental microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Genomic insights into an optrA-carrying plasmid associated with linezolid resistance in clinical Enterococcus faecalis isolates, Argentina.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026
    Article
  2. Cross-Sector Antimicrobial Resistance and Virulence inAntibiotics (Basel, Switzerland) · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. New microbes and new infections · 2026
    Article
  7. New microbes and new infections · 2026
    Article
  8. One Health Insights intoInternational journal of molecular sciences · 2026
    Article
  9. Article
  10. Article
  11. Review
  12. Genomic Characterization and Safety Evaluation ofAntibiotics (Basel, Switzerland) · 2025
    Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Ana C Almeida-SantosUCIBIO, Unidade de Ciências Biomoleculares Aplicadas, Faculdade de Farmácia, Universidade do Porto, Porto, Portugal.ORCID 0000-0001-6711-4780
Bárbara DuarteUCIBIO, Unidade de Ciências Biomoleculares Aplicadas, Faculdade de Farmácia, Universidade do Porto, Porto, Portugal.ORCID 0000-0003-4239-1575
Ana P TedimGrupo de Investigación Biomédica en Sepsis - BioSepsis, Instituto de Investigación Biomédica de Salamanca (IBSAL), Salamanca, Spain.ORCID 0000-0003-1016-7173
Maria J TeixeiraLaboratório Associado i4HB, Instituto para a Saúde e a Bioeconomia, Instituto Universitário de Ciências da Saúde, IUCS-CESPU, Gandra, Portugal.
Joana C PrataLaboratório Associado i4HB, Instituto para a Saúde e a Bioeconomia, Instituto Universitário de Ciências da Saúde, IUCS-CESPU, Gandra, Portugal.ORCID 0000-0001-7814-3659
Rui M S AzevedoLaboratório Associado i4HB, Instituto para a Saúde e a Bioeconomia, Instituto Universitário de Ciências da Saúde, IUCS-CESPU, Gandra, Portugal.ORCID 0000-0002-8904-002X
Carla NovaisUCIBIO, Unidade de Ciências Biomoleculares Aplicadas, Faculdade de Farmácia, Universidade do Porto, Porto, Portugal.
Luísa PeixeUCIBIO, Unidade de Ciências Biomoleculares Aplicadas, Faculdade de Farmácia, Universidade do Porto, Porto, Portugal.ORCID 0000-0001-5810-8215
Ana R FreitasUCIBIO, Unidade de Ciências Biomoleculares Aplicadas, Faculdade de Farmácia, Universidade do Porto, Porto, Portugal.ORCID 0000-0002-7326-4133

Funding

MEC | Fundação para a Ciência e a Tecnologia (FCT) https://doi.org/10.54499/EXPL/SAU-INF/0261/2021MEC | Fundação para a Ciência e a Tecnologia (FCT) LA/P/0140/2020MEC | Fundação para a Ciência e a Tecnologia (FCT) UI/BD/151317/2021MEC | Fundação para a Ciência e a Tecnologia (FCT) UIDB/04378/2020MEC | Fundação para a Ciência e a Tecnologia (FCT) UIDP/04378/2020
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Anti-Bacterial AgentsBacteriocinsEnterococcusGastrointestinal MicrobiomeLinezolidVancomycinAdultDrug Resistance, BacterialFecesFemaleHumansMaleMicrobial Sensitivity TestsMiddle AgedPortugalAnti-Bacterial AgentsBacteriocinsLinezolidVancomycinantimicrobial resistancebacteriocinsEnterococcus lactisEnterococcus spp.healthy humanslinezolid resistanceVVE

Identifiers

PMID39699199
PMCPMC11784074

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.